Aumolertinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Aumolertinib, covering 2023-04-13 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC [Phase 3]